These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transfer factor (TFd). Part IV. Transfer factor in mucocutaneous candidiasis treatment. Miksiewicz-Wasilewska H; Grubek-Jaworska A; Plucińska M; Podsiadło B; Krakówka P; Rzucidło L Mater Med Pol; 1981; 13(2):108-12. PubMed ID: 7345253 [No Abstract] [Full Text] [Related]
5. [The natural killer and fungicidal activity of the peripheral blood mononuclear cells in candidiasis]. Golikova EA; Karaev ZO; Mirzabalaeva AK Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):61-4. PubMed ID: 1950289 [TBL] [Abstract][Full Text] [Related]
6. Cultured thymus fragment transplant in chronic candidiasis complicated by oral carcinoma. Hong R; Dibbell DG Lancet; 1981 Apr; 1(8223):773-4. PubMed ID: 6110968 [No Abstract] [Full Text] [Related]
7. Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor. Corbeel L; Ceuppens JL; Van den Berghe G; Claeys H; Casteels-Van Daele M Eur J Pediatr; 1984 Nov; 143(1):45-8. PubMed ID: 6096150 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in cancer treatment. A comparative study with chronic muco-cutaneous candidiasis. Higgs JM Clin Oncol; 1980 Jun; 6(2):95-112. PubMed ID: 6967793 [No Abstract] [Full Text] [Related]